Terms: = Endocrine gland cancer AND CREB1, ENSG00000118260, 1385 AND Prognosis
6 results:
1. The creb1/WNK1 axis promotes the tumorigenesis of ovarian cancer via regulating HIF-1.
Ma Y; Zong H; Pan P; Shang H; Yang X
Exp Cell Res; 2024 May; 438(1):114006. PubMed ID: 38599542
[TBL] [Abstract] [Full Text] [Related]
2. MEX3A induces the development of thyroid cancer via targeting creb1.
Feng G; Wang P; Zhang H; Cheng S; Xing Y; Wang Y
Cell Biol Int; 2023 Nov; 47(11):1843-1853. PubMed ID: 37529875
[TBL] [Abstract] [Full Text] [Related]
3. Expression of CAMK1 and its association with clinicopathologic characteristics in pancreatic cancer.
Lei Y; Yu T; Li C; Li J; Liang Y; Wang X; Chen Y; Wang X
J Cell Mol Med; 2021 Jan; 25(2):1198-1206. PubMed ID: 33342045
[TBL] [Abstract] [Full Text] [Related]
4. Multi-Omics Analysis Identifying Key Biomarkers in Ovarian cancer.
Li JY; Li CJ; Lin LT; Tsui KH
Cancer Control; 2020; 27(1):1073274820976671. PubMed ID: 33297760
[TBL] [Abstract] [Full Text] [Related]
5. Accuracy of Grading in Pancreatic Neuroendocrine Neoplasms and Effect on Survival Estimates: An Institutional Experience.
Trikalinos NA; Chatterjee D; Lee J; Liu J; Williams G; Hawkins W; Hammill C
Ann Surg Oncol; 2020 Sep; 27(9):3542-3550. PubMed ID: 32206954
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathologic Features and Risk Factors for Recurrence of Mucinous Borderline Ovarian Tumors: A Retrospective Study With Follow-up of More Than 10 Years.
Sun L; Li N; Song Y; Wang G; Zhao Z; Wu L
Int J Gynecol Cancer; 2018 Nov; 28(9):1643-1649. PubMed ID: 30365456
[TBL] [Abstract] [Full Text] [Related]
